DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins are 15




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_0996Cinacalcet Hydrochloride
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperparathyroidism
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (51.525 %)
Approved
27476412
DrugRepV_1145Fludrocortisone Acetate
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Addison disease and salt-losing adrenogenital syndrome
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (46.635 %)
Approved
27476412
DrugRepV_1219Methimazole
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperthyroidism | Goiter | Graves disease | Psoriasis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (47.56 %)
Approved
27476412
DrugRepV_1244Propylthiouracil
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperthyroidism
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (46.32 %)
Approved, Investigational
27476412
DrugRepV_1328Liothyronine Sodium
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hypothyroidism | Thyroid cancer
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (48.935 %)
Approved, Vet approved
27476412
DrugRepV_1401Cortisone Acetate
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Allergies, skin problems, asthma and arthritis
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (45.925 %)
Approved
27476412
DrugRepV_1440Levothyroxine Sodium
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hypothyroidism
Zika virus
MEX_I_7
NA
Fluorescence-based assay
Decrease (45.275 %)
Approved
27476412
DrugRepV_2191L-Thyroxine
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hypothyroidism
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (10.9745889 %)
Approved
27742486
DrugRepV_2221Doxercalciferol
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Secondary hyperparathyroidism
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (7.31888883 %)
Approved
27742486
DrugRepV_2355Methylthiouracil
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperthyroidism
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (3.1440867 %)
Experimental
27742486
DrugRepV_2398Trilostane
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Cushing's syndrome
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (2.24049946 %)
Approved
27742486
DrugRepV_2496Deflazacort
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Duchenne muscular dystrophy
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
No significant decrease (0.19023033 %)
Approved
27742486
DrugRepV_2621Propylthiouracil
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperthyroidism
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-1.8029587 %)
Approved, Investigational
27742486
DrugRepV_2755Cortisone Acetate
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Allergies, skin problems, asthma and arthritis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-4.0138374 %)
Approved
27742486
DrugRepV_2896Methimazole
Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins
Hyperthyroidism | Goiter | Graves disease | Psoriasis
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-9.0110469 %)
Approved
27742486